Last updated on March 2019

To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis


Brief description of study

To demonstrate non-inferiority in efficacy of FE 999315 to mesalazine in patients with mild to moderate active ulcerative colitis after 8 weeks of treatment.

Clinical Study Identifier: NCT03412682

Contact Investigators or Research Sites near you

Start Over

Global Clinical Compliance

Ferring Investigator Site JPN57
Toyonaka-shi, Japan
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN39
Suita-shi, Japan
3.07miles
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN10
Osaka-shi, Japan
6.32miles
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN26
Osaka-shi, Japan
6.32miles
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN30
Osaka-shi, Japan
6.32miles
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN13
Nishinomiya-shi, Japan
7.88miles
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN40
Nishinomiya-shi, Japan
7.88miles
  Connect »

Global Clinical Compliance

Ferring Investigator Site JPN21
Takatsuki-shi, Japan
9.49miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.